Piacra lépett a Neumann Diagnostics

Molecular assays developer NEUMANN Diagnostics Ltd. today unveiled its CONFIDENCE™ molecular test portfolio setting a new standard in cervical cancer screening.

Forrás: PRNEWSWIRE : teljes cikk >>